4//SEC Filing
Reine Allan 4
Accession 0001894562-25-000020
CIK 0001894562other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:50 PM ET
Size
434.7 KB
Accession
0001894562-25-000020
Insider Transaction Report
Form 4
Reine Allan
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2025-05-08+75,000→ 850,000 totalExercise: $6.80Exp: 2034-01-17→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Represents an option initially granted to the Reporting Person on January 17, 2024, a portion of which shares underlying this option shall vest upon the achievement of certain performance milestones. On May 8, 2025, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved, resulting in the vesting of 75,000 shares.
Issuer
Prime Medicine, Inc.
CIK 0001894562
Entity typeother
Related Parties
1- filerCIK 0001714023
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:50 PM ET
- Size
- 434.7 KB